PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced that an abstract relating to the efficacy of Microcyn® Technology for the treatment of atopic dermatitis was peer reviewed and presented at the Third Congress of the World Union of Wound Healing Societies held in Toronto, Ontario on June 4-8. The conference, which occurs once every four years and is considered one of the premier wound healing events in the world, is a showcase for the latest advances in wound care.
